Beijing Kawin Technology Share-Holding Co., Ltd. (688687.SS) SHH
16.64
-0.4(-2.35%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Beijing Kawin Technology Share-Holding Co., Ltd.
Address
Building 3, No. 6, Rongjing East Street
Beijing, 100176
China
Phone
86 10 6789 2271
Website
Sector
Healthcare
Industry
Biotechnology
Employees
584
First IPO Date
February 08, 2021
Key Executives
| Name | Title | Pay | Year Born |
| Xiao Xu | Vice President | 0 | 1974 |
| Jifeng Shi | Vice President, Chief Research Officer, Core Technical Personnel & Director | 0 | 1974 |
| Zhan Wang | Chief Human Resources Officer | 0 | 1981 |
| Shan Liu | Head of Antibody Drug Development Department & Core Technical Personnel | 0 | 1988 |
| Chongfei He | Vice President, Secretary to the Board & Chief Financial Officer | 0 | 1969 |
| Zhenqiang Du | Vice President | 0 | 1976 |
| Hong Juan Liu | Accounting Supervisor | 0 | N/A |
| Yan Cui | Director of Human Resources Department & Employee Representative Supervisor | 0 | 1984 |
| Huan Wang | Executive Vice President & Director | 0 | 1979 |
| Jian Tang | Vice President | 0 | 1978 |
| Desheng Zhou | President & Chairman of the Board | 0 | 1971 |
| Xiang Li | Manager of Information Strategy Research Department & Core Technical Personnel | 0 | 1983 |
| Lu Yang | Deputy GM of Beiyi Protein Drug R&D and Core Technical Personnel | 0 | 1983 |
Description
Beijing Kawin Technology Share-Holding Co., Ltd. engages in the development and production of pharmaceutical products primarily in the areas of liver diseases in China. The company's products include recombinant human interferon alfa-2b injection and compound glycyrrhizin. It provides active pharmaceutical ingredients; clinical research services for biological product development, which include drug substancesfermentation and purification, drug productformulation, and analytical methods development; and contract manufacturing services. The company also serves customers in Pakistan, Colombia, Philippines, Vietnam, Russia, Cambodia, and others. It has strategic partnership with Legend Capital, Haitong Capital, and Cybernaut. The company was founded in 2008 and is based in Beijing, China.
